Sensus Healthcare Issues Reminder That its Second Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, August 8, 2024
Sensus Healthcare (Nasdaq: SRTS) has announced a conference call scheduled for Thursday, August 8, 2024, at 4:30 p.m. Eastern time to discuss its second quarter 2024 financial results and provide a business update. The company, which specializes in non-invasive treatments for oncological and non-oncological conditions, encourages participants to pre-register for the call. Those unable to pre-register can dial in directly. The call will also be webcast live and accessible through the company's website. A telephone replay will be available until September 8th, and an archived webcast will be accessible in the Investor Relations section of the website.
Sensus Healthcare (Nasdaq: SRTS) ha annunciato una conferenza telefonica programmata per giovedì 8 agosto 2024, alle 16:30 ora dell'Est per discutere i suoi risultati finanziari del secondo trimestre 2024 e fornire un aggiornamento aziendale. L'azienda, che si specializza in trattamenti non invasivi per condizioni oncologiche e non oncologiche, incoraggia i partecipanti a preregistrarsi per la chiamata. Coloro che non riescono a preregistrarsi possono partecipare direttamente. La chiamata sarà inoltre trasmessa in diretta e accessibile attraverso il sito web dell'azienda. Una registrazione telefonica sarà disponibile fino all'8 settembre e un webcast archiviato sarà accessibile nella sezione Relazioni con gli Investitori del sito web.
Sensus Healthcare (Nasdaq: SRTS) ha anunciado una conferencia telefónica programada para el jueves 8 de agosto de 2024, a las 4:30 p.m. hora del Este para discutir sus resultados financieros del segundo trimestre de 2024 y proporcionar una actualización empresarial. La empresa, que se especializa en tratamientos no invasivos para condiciones oncológicas y no oncológicas, anima a los participantes a preinscribirse para la llamada. Aquellos que no puedan preinscribirse pueden llamar directamente. La llamada también se transmitirá en vivo y será accesible a través del sitio web de la empresa. Se dispondrá de una grabación telefónica hasta el 8 de septiembre, y un webcast archivado estará disponible en la sección de Relaciones con Inversores del sitio web.
센서스 헬스케어(Sensus Healthcare, Nasdaq: SRTS)는 2024년 8월 8일 목요일 오후 4시 30분 동부 표준시에 2024년 2분기 재무 결과를 논의하고 비즈니스 업데이트를 제공하기 위한 컨퍼런스 콜을 일정으로 발표했습니다. 종양 및 비종양 질환에 대한 비침습적 치료를 전문으로 하는 이 회사는 참가자들이 통화에 사전 등록할 것을 권장합니다. 사전 등록이 불가능한 분들은 직접 전화하실 수 있습니다. 통화는 실시간 웹 캐스트로 중계되며 회사 웹사이트를 통해 접근할 수 있습니다. 전화 재생은 9월 8일까지 이용 가능하며, 보관된 웹 캐스트는 웹사이트의 투자자 관계 섹션에서 접근할 수 있습니다.
Sensus Healthcare (Nasdaq: SRTS) a annoncé une conférence téléphonique prévue pour jeudi 8 août 2024 à 16h30, heure de l’Est, afin de discuter de ses résultats financiers du deuxième trimestre 2024 et d'offrir une mise à jour sur l'entreprise. La société, spécialisée dans les traitements non invasifs pour les affections oncologiques et non oncologiques, encourage les participants à s'inscrire à l'avance pour l'appel. Ceux qui ne peuvent pas s'inscrire à l'avance peuvent se connecter directement. L'appel sera également diffusé en direct et accessible via le site web de l'entreprise. Un replay téléphonique sera disponible jusqu'au 8 septembre, et un webinaire archivé sera accessible dans la section Relations Investisseurs du site internet.
Sensus Healthcare (Nasdaq: SRTS) hat eine Telefonkonferenz für Donnerstag, den 8. August 2024, um 16:30 Uhr Eastern Time angekündigt, um über die finanziellen Ergebnisse des zweiten Quartals 2024 zu diskutieren und ein Unternehmensupdate zu geben. Das Unternehmen, das sich auf nicht-invasive Behandlungen für onkologische und nicht-onkologische Erkrankungen spezialisiert hat, ermutigt die Teilnehmer, sich im Voraus für den Anruf anzumelden. Teilnehmer, die sich nicht im Voraus anmelden können, können direkt anrufen. Der Anruf wird auch live über das Internet übertragen und ist über die Website des Unternehmens zugänglich. Eine Telefonaufzeichnung wird bis zum 8. September verfügbar sein, und eine archivierte Webübertragung ist im Bereich Investorenbeziehungen der Website zugänglich.
- None.
- None.
BOCA RATON, Fla. , Aug. 01, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, reminds investors that management will hold a conference call on Thursday, August 8, 2024 at 4:30 p.m. Eastern time to discuss the financial results for the second quarter of 2024. In addition, management will provide a business update and a discussion on recent and upcoming milestones.
Participants are encouraged to pre-register for the conference call using this link. Upon registration participants will receive a unique dial in number that will permit them to bypass the live operator. Participants may pre-register at any time, including up to and after the call start time. Those without internet access or unable to pre-register may access the conference call by dialing, 844-481-2811 (U.S. and Canada Toll Free) or 412-317-0676 (International). Please direct the operator to be connected to the Sensus Healthcare conference call.
The call will be webcast live and can be accessed at this link, which also may be found in the Investor Relations section of the Company’s website at www.sensushealthcare.com.
Following the conclusion of the conference call, a telephone replay will be available until September 8th, and can be accessed by dialing 877-344-7529 (U.S. Toll Free), 855-669-9658 (Canada Toll Free), or 412-317-0088 (International). At the system prompt, dial the replay code – 2699495 – followed by the # sign. Playback will automatically begin. An archived webcast of the call will also be available in the Investor Relations section of the Company’s website for a period of time.
About Sensus Healthcare, Inc.
Sensus Healthcare, Inc. is a global pioneer in the development and delivery of non-invasive treatments for skin cancer and keloids. Leveraging its cutting-edge superficial radiotherapy (SRT and IG-SRT) technology, the company provides healthcare providers with a highly effective, patient-centric treatment platform. With a dedication to driving innovation in radiation oncology, Sensus Healthcare offers solutions that are safe, precise, and adaptable to a variety of clinical settings. For more information, please visit www.sensushealthcare.com.
Contact:
LHA Investor Relations
Kim Sutton Golodetz
212-838-3777
kgolodetz@lhai.com
# # #
FAQ
When is Sensus Healthcare (SRTS) releasing its Q2 2024 financial results?
How can investors participate in Sensus Healthcare's (SRTS) Q2 2024 earnings call?
Will there be a replay available for Sensus Healthcare's (SRTS) Q2 2024 earnings call?
What topics will be covered in Sensus Healthcare's (SRTS) upcoming conference call?
